Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03907488 |
|---|---|
| Brief Title: | Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma |
| First Submitted : | April 8, 2019 |
| First Submitted that Met QC Criteria : | April 8, 2019 |
| First Posted : | April 9, 2019 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |